September 20,2020: Drug Controller General of India (DCGI) para Tata Group and CSIR-IGIB para Tata Group’s Feluda, COVID19 test laga commercial launch nimete manishe.
Etu test toh ICMR guidelines saikena etu te meeting high quality benchmarks 96% sensitivity aro 98% specificity thakikena novel coronavirus thuribole nimete bonaishe.
Union science & technology ministry para statement diya te koishe “etu test para indigenously developed, cutting-edge CRISPR technology chulaishe etu bi genomic sequence SARS-CoV-2 virus chulaikena .CRISPR toh ekta genome editing technology ase etu bi beemar thuribole nimete.”
Ministry koishe Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) test toh duniya laga akhe wala diagnostic test ase ekta specially-adapted Cas9 protein olabole nimete etu virus thuribole nimete kuntu para covid19 pai.
Etu toh ekta bhal achievement ase Indian scientific community nimete etu bi R&D para high-accuracy, scalable and reliable test komti hoilebi 100 din bithor te paa toh.
Tata CRISPR test para accuracy levels paar kurishe traditional RT-PCR tests nimete etu bi quicker turnaround time, less expensive equipment, aro bhal para chulaikena.
Etu kaam huwa toh scientific community aro industry khan milikena thaka nimete ase.Ministry koishe” Tata Group t oh CSIR-IGIB and ICMR logote kaam kurishe etu bi high-quality test bonabole nimete kuntu para desh ke modot kuribo Covid-19 testing toh joldi olabole nimete etu te ‘Made in India’ product logote kuntu toh safe reliable affordable aro accessible ase.”
Girish Krishnamurthy, CEO, TATA Medical and Diagnostics Ltd, etu nutun development uporte kotha kurikena koishe “Tata CRISPR test laga approval COVID-19 nimete boost kuribo desh laga kaam nimete etu pandemic te ladai kuribole nimete.”
Krishnamurthy koishe”etu Tata CRISPR test laga commercialisation para R&D talent laga kaam khan dikhaishe desh te kun kha milishe India laga contribution toh global healthcare and scientific research world ke bodli kuribo.”
Dr Shekhar C Mande, DG-CSIR para CSIR-IGIB team of scientists and students, TATA Sons and DCGI ke khushi janaishe etu kaam kura nimete aro enia samay te milikena kaam kura nimete.
Dr Anurag Agrawal, director, CSIR-IGIB, para CSIR sickle cell mission genome diagnostics and therapeutics nimete kaam kura nimete kuntu para nutun knowledge paishe kuntu toh harness kuribole paribo joldi hi ekta nutun new diagnostic test SARS-CoV-2 nimete bonabole nimete.
Tai koishe etu para dikhaishe scientific knowledge aro technology laga interconnectedness aro young research teamDr Debojyoti Chakraborty and Dr SouvikMait laga motivation te.
